Artigos de revistas sobre o tema "FK-506 (Drug)"
Crie uma referência precisa em APA, MLA, Chicago, Harvard, e outros estilos
Veja os 50 melhores artigos de revistas para estudos sobre o assunto "FK-506 (Drug)".
Ao lado de cada fonte na lista de referências, há um botão "Adicionar à bibliografia". Clique e geraremos automaticamente a citação bibliográfica do trabalho escolhido no estilo de citação de que você precisa: APA, MLA, Harvard, Chicago, Vancouver, etc.
Você também pode baixar o texto completo da publicação científica em formato .pdf e ler o resumo do trabalho online se estiver presente nos metadados.
Veja os artigos de revistas das mais diversas áreas científicas e compile uma bibliografia correta.
Shaw, L. M., e K. L. Brayman. "FK-506 therapeutic drug monitoring". Clinical Chemistry 40, n.º 12 (1 de dezembro de 1994): 2207–8. http://dx.doi.org/10.1093/clinchem/40.12.2207.
Winkler, M., B. Ringe, J. Baumann, M. Loss, K. Wonigeit e R. Pichlmayr. "Plasma vs whole blood for therapeutic drug monitoring of patients receiving FK 506 for immunosuppression". Clinical Chemistry 40, n.º 12 (1 de dezembro de 1994): 2247–53. http://dx.doi.org/10.1093/clinchem/40.12.2247.
Dumont, F. J., M. J. Staruch, S. L. Koprak, J. J. Siekierka, C. S. Lin, R. Harrison, T. Sewell, V. M. Kindt, T. R. Beattie e M. Wyvratt. "The immunosuppressive and toxic effects of FK-506 are mechanistically related: pharmacology of a novel antagonist of FK-506 and rapamycin." Journal of Experimental Medicine 176, n.º 3 (1 de setembro de 1992): 751–60. http://dx.doi.org/10.1084/jem.176.3.751.
Rokaw, M. D., M. E. West, P. M. Palevsky e J. P. Johnson. "FK-506 and rapamycin but not cyclosporin inhibit aldosterone-stimulated sodium transport in A6 cells". American Journal of Physiology-Cell Physiology 271, n.º 1 (1 de julho de 1996): C194—C202. http://dx.doi.org/10.1152/ajpcell.1996.271.1.c194.
Di Padova, F. E. "Pharmacology of CsA and FK-506". Perspectives in Drug Discovery and Design 2, n.º 1 (agosto de 1994): 49–56. http://dx.doi.org/10.1007/bf02171736.
Goulet, Mark T., Kathleen M. Rupprecht, Peter J. Sinclair, Matthew J. Wyvratt e William H. Parsons. "The medicinal chemistry of FK-506". Perspectives in Drug Discovery and Design 2, n.º 1 (agosto de 1994): 145–62. http://dx.doi.org/10.1007/bf02171741.
Petros, Andrew M., Gerd Gemmecker, Placido Neri, Edward T. Olejniczak, David Nettesheim, Robert X. Xu, Earl G. Gubbins, Harriet Smith e Stephen W. Fesik. "NMR studies of an FK-506 analog, [U-carbon-13]ascomycin, bound to FK-506-binding protein". Journal of Medicinal Chemistry 35, n.º 13 (junho de 1992): 2467–73. http://dx.doi.org/10.1021/jm00091a015.
Kay, John E., Senam E. A. Doe e C. Robin Benzie. "The mechanism of action of the immunosuppressive drug FK-506". Cellular Immunology 124, n.º 1 (novembro de 1989): 175–81. http://dx.doi.org/10.1016/0008-8749(89)90121-4.
O'connor, Stephen P., Robert L. Ellsworth, Mary Nallin Omstead, Rosalind G. Jenkins e Louis Kaplan. "The preparation of 14C-labeled FK-506". Journal of Labelled Compounds and Radiopharmaceuticals 31, n.º 2 (fevereiro de 1992): 103–8. http://dx.doi.org/10.1002/jlcr.2580310205.
Jusko, William J. "Analysis of Tacrolimus (FK 506) in Relation to Therapeutic Drug Monitoring". Therapeutic Drug Monitoring 17, n.º 6 (dezembro de 1995): 596–601. http://dx.doi.org/10.1097/00007691-199512000-00009.
Clardy, Jon. "Structural studies on FK-506, cyclosporin A and their immunophilin complexes". Perspectives in Drug Discovery and Design 2, n.º 1 (agosto de 1994): 127–44. http://dx.doi.org/10.1007/bf02171740.
DOE, SENAM E. A., C. ROBIN BENZIE e JOHN E. KAY. "Early effects of the immunosuppressive drug FK-506 on signal transduction in lymphocytes". Biochemical Society Transactions 18, n.º 3 (1 de junho de 1990): 451–52. http://dx.doi.org/10.1042/bst0180451.
Takabayashi, Katsuhiko, Takao Koike, Kazuhiro Kurasawa, Ryutaro Matsumura, Toshiko Sato, Hisao Tomioka, Isao Ito, Takashi Yoshiki e Sho Yoshida. "Effect of FK-506, a novel immunosuppressive drug on murine systemic lupus erythematosus". Clinical Immunology and Immunopathology 51, n.º 1 (abril de 1989): 110–17. http://dx.doi.org/10.1016/0090-1229(89)90211-0.
Patel, S. S., M. S. Patel, S. Salampure, B. Vishwanath e N. M. Patel. "Development and Evaluation of Liposomes for Topical Delivery of Tacrolimus (Fk-506)". Journal of Scientific Research 2, n.º 3 (24 de agosto de 2010): 585. http://dx.doi.org/10.3329/jsr.v2i3.3258.
Shitrit, David, Jacob E. Ollech, Ayelet Ollech, Ilana Bakal, Milton Saute, Gideon Sahar e Mordechai R. Kramer. "Itraconazole Prophylaxis in Lung Transplant Recipients Receiving Tacrolimus (FK 506): Efficacy and Drug Interaction". Journal of Heart and Lung Transplantation 24, n.º 12 (dezembro de 2005): 2148–52. http://dx.doi.org/10.1016/j.healun.2005.05.003.
Acemoglu, Murat, Hendrik Andres e Thomas Moenius. "Regio- and stereoselective preparation of ascomycin-d1 and FK 506-d1". Journal of Labelled Compounds and Radiopharmaceuticals 45, n.º 5 (2002): 361–70. http://dx.doi.org/10.1002/jlcr.558.
Kramer, Mordechai R., Anat Amital, Leonardo Fuks e David Shitrit. "Voriconazole and itraconazole in lung transplant recipients receiving tacrolimus (FK 506): efficacy and drug interaction". Clinical Transplantation 25, n.º 2 (16 de dezembro de 2010): E163—E167. http://dx.doi.org/10.1111/j.1399-0012.2010.01373.x.
O'Keefe, Stephen J., e Edward A. O'Neill. "Cyclosporin A and FK-506: Immunosuppression, inhibition of transcription and the role of calcineurin". Perspectives in Drug Discovery and Design 2, n.º 1 (agosto de 1994): 85–102. http://dx.doi.org/10.1007/bf02171738.
White, James D., Jörg Deerberg, Steven G. Toske e Takayuki Yakura. "Application of stereocontrolled aldol coupling to synthesis of segments of immunosuppressants FK-506 and rapamycin". Tetrahedron 65, n.º 33 (agosto de 2009): 6635–41. http://dx.doi.org/10.1016/j.tet.2009.06.030.
Oyouni, AtifAbdulwahab A., Shalini Saggu, Ehab Tousson, Anand Mohan e Abdullah Farasani. "Mitochondrial nephrotoxicity induced by tacrolimus (FK-506) and modulatory effects of Bacopa monnieri (Farafakh) of Tabuk Region". Pharmacognosy Research 11, n.º 1 (2019): 20. http://dx.doi.org/10.4103/pr.pr_100_18.
Schnider, Jonas T., Matthias Weinstock, Jan A. Plock, Mario G. Solari, Raman Venkataramanan, Xin Xiao Zheng e Vijay S. Gorantla. "Site-Specific Immunosuppression in Vascularized Composite Allotransplantation: Prospects and Potential". Clinical and Developmental Immunology 2013 (2013): 1–7. http://dx.doi.org/10.1155/2013/495212.
Kay, John E., e C. Robin Benzie. "T lymphocyte activation through the C28 pathway is insensitive to inhibition by the immunosuppressive drug FK-506". Immunology Letters 23, n.º 2 (dezembro de 1989): 155–59. http://dx.doi.org/10.1016/0165-2478(89)90129-6.
Shevchenko, V. P., I. Yu Nagaev, N. F. Myasoedov, H. Andres, T. Moenius e A. Susan. "Synthesis of tritiated Cyclosporin A and FK-506 by metal-catalyzed hydrogen isotope exchange". Journal of Labelled Compounds and Radiopharmaceuticals 47, n.º 7 (junho de 2004): 407–14. http://dx.doi.org/10.1002/jlcr.827.
Chung, Shu-Ying, Fu-Chou Cheng, Ming-Shih Lee, Jing-Ying Lin, Ming-Cheng Lin e Ming-Fu Wang. "Ginkgo biloba Leaf Extract (EGb761) Combined with Neuroprotective Agents Reduces the Infarct Volumes of Gerbil Ischemic Brain". American Journal of Chinese Medicine 34, n.º 05 (janeiro de 2006): 803–17. http://dx.doi.org/10.1142/s0192415x06004302.
Wong, S. H. Y., B. Ghodgaonkar, P. Fong, B. Campbell, J. F. Burdick e F. Boctor. "Supercritical Fluid Chromatography for Therapeutic Drug Monitoring of Immunosuppressants: Selectivity for Cyclosporine A, Fk 506 (Tacrolimus), and Rapamycin". Journal of Liquid Chromatography 17, n.º 10 (junho de 1994): 2093–109. http://dx.doi.org/10.1080/10826079408013534.
Lhoest, G., N. Maton, A. Laurent e R. K. Verbeeck. "Isolation and identification of a FK-506 C36–C37 dihydrodiol from erythromycin-induced rabbit liver microsomes". Journal of Pharmaceutical and Biomedical Analysis 12, n.º 2 (fevereiro de 1994): 235–41. http://dx.doi.org/10.1016/0731-7085(94)90034-5.
Yu, JS, S. Lee, HJ Eom, HR Kang, SR Lee, TK Lee, J. Baek et al. "Protective effect of Korean red ginseng against FK-506-induced damage in LLC-PK1 cells". Planta Medica 81, S 01 (14 de dezembro de 2016): S1—S381. http://dx.doi.org/10.1055/s-0036-1596887.
Cryan, John, Shirley H. Y. Hung, Gregory Wiederrecht, Nolan H. Sigal e John J. Siekierka. "FKBP, the binding protein for the immunosuppressive drug, FK-506, is not an inhibitor of protein kinase C activity". Biochemical and Biophysical Research Communications 180, n.º 2 (outubro de 1991): 846–52. http://dx.doi.org/10.1016/s0006-291x(05)81142-8.
Petros, A. M., R. T. Gampe, G. Gemmecker, P. Neri, T. F. Holzman, R. Edalji, J. Hochlowski, M. Jackson e J. McAlpine. "NMR studies of an FK-506 analog [U-13C]ascomycin, bound to FKBP: conformation and regions of ascomycin involved in binding". Journal of Medicinal Chemistry 34, n.º 9 (setembro de 1991): 2925–28. http://dx.doi.org/10.1021/jm00113a037.
Banholzer, R., A. P. Nair, H. H. Hirsch, X. F. Ming e C. Moroni. "Rapamycin destabilizes interleukin-3 mRNA in autocrine tumor cells by a mechanism requiring an intact 3' untranslated region." Molecular and Cellular Biology 17, n.º 6 (junho de 1997): 3254–60. http://dx.doi.org/10.1128/mcb.17.6.3254.
Bansal, Puneet, e Anil Kumar. "P1-194: Novel drug strategies and molecular mechanisms of lycopene, FK-506 and venlafaxine against 3-NP induced Huntington's-like symptoms in rats". Alzheimer's & Dementia 8, n.º 4S_Part_5 (julho de 2012): P174—P175. http://dx.doi.org/10.1016/j.jalz.2012.05.472.
Tran, Quang Hieu Dé, Elizabeth Guay, Suzanne Chartier e Jacqueline Tousignant. "Tacrolimus in Dermatology". Journal of Cutaneous Medicine and Surgery 5, n.º 4 (julho de 2001): 329–35. http://dx.doi.org/10.1177/120347540100500409.
Furue, Masutaka, Atsushi Osada e Kunihiko Tamaki. "Inhibition of contact hypersensitivity by an anti-allergic drug, azelastine, is likely to be mediated by its novel immunosuppressive effects distinct from FK-506". Journal of Dermatological Science 6, n.º 1 (agosto de 1993): 75. http://dx.doi.org/10.1016/0923-1811(93)91148-n.
WOO, J., C. S. K. ROSS, J. I. MILTON e A. W. THOMSON. "Immunosuppressive activity of FK-506 in rats: flow cytometric analysis of lymphocyte populations in blood, spleen and thymus during treatment and following drug withdrawal". Clinical & Experimental Immunology 79, n.º 1 (28 de junho de 2008): 109–14. http://dx.doi.org/10.1111/j.1365-2249.1990.tb05136.x.
Vannucchi, AM, A. Grossi, A. Bosi, D. Rafanelli, M. Statello, S. Guidi, R. Saccardi e P. Rossi-Ferrini. "Effects of cyclosporin A on erythropoietin production by the human Hep3B hepatoma cell line". Blood 82, n.º 3 (1 de agosto de 1993): 978–84. http://dx.doi.org/10.1182/blood.v82.3.978.978.
Vannucchi, AM, A. Grossi, A. Bosi, D. Rafanelli, M. Statello, S. Guidi, R. Saccardi e P. Rossi-Ferrini. "Effects of cyclosporin A on erythropoietin production by the human Hep3B hepatoma cell line". Blood 82, n.º 3 (1 de agosto de 1993): 978–84. http://dx.doi.org/10.1182/blood.v82.3.978.bloodjournal823978.
KASS, LEONARD, DORETTE Z. ELLIS, JANICE PELLETIER, NATHAN E. TABLEMAN e SAMUEL C. EDWARDS. "Inhibition of the calcineurin-like protein phosphatase activity in Limulus ventral eye photoreceptor cells alters the characteristics of the spontaneous quantal bumps and the light-mediated inward currents, and enhances arrestin phosphorylation". Visual Neuroscience 15, n.º 6 (novembro de 1998): 1039–49. http://dx.doi.org/10.1017/s0952523898156031.
Lopatynska-Mazurek, Malgorzata, Lukasz Komsta, Ewa Gibula-Tarlowska e Jolanta H. Kotlinska. "Aversive Learning Deficits and Depressive-Like Behaviors Are Accompanied by an Increase in Oxidative Stress in a Rat Model of Fetal Alcohol Spectrum Disorders: The Protective Effect of Rapamycin". International Journal of Molecular Sciences 22, n.º 13 (30 de junho de 2021): 7083. http://dx.doi.org/10.3390/ijms22137083.
Lemster, B., L. L. Huang, W. Irish, J. Woo, P. B. Carroll, K. Abu-Elmagd, H. R. Rilo et al. "Influence of FK 506 (Tacrolimus) On Circulating CD4+T Cells Expressing Cd25 and Cd45ra Antigens in 19 Patients with Chronic Progressive Multiple Sclerosis Participating in an Open Label Drug Safety Trial". Autoimmunity 19, n.º 2 (janeiro de 1994): 89–98. http://dx.doi.org/10.3109/08916939409009536.
Chow, Kai Uwe, Daniel Nowak, Soo-Zin Kim, Bernd Schneider, Martina Komor, Simone Boehrer, Paris S. Mitrou, Dieter Hoelzer, Eckhart Weidmann e Wolf-Karsten Hofmann. "In Vivo Drug-Response in Patients with Leukemic Non-Hodgkin’s Lymphomas Is Predicted by In Vitro Chemosensitivity Testing and Gene Expression Profiling." Blood 104, n.º 11 (16 de novembro de 2004): 2273. http://dx.doi.org/10.1182/blood.v104.11.2273.2273.
Yue, Gang, Robert S. Edinger, Hui-Fang Bao, John P. Johnson e Douglas C. Eaton. "The effect of rapamycin on single ENaC channel activity and phosphorylation in A6 cells". American Journal of Physiology-Cell Physiology 279, n.º 1 (1 de julho de 2000): C81—C88. http://dx.doi.org/10.1152/ajpcell.2000.279.1.c81.
Edinger, Robert S., Simon C. Watkins, David Pearce e John P. Johnson. "Effect of immunosuppressive agents on glucocorticoid receptor function in A6 cells". American Journal of Physiology-Renal Physiology 283, n.º 2 (1 de agosto de 2002): F254—F261. http://dx.doi.org/10.1152/ajprenal.00337.2001.
Tumlin, J. A., J. T. Someren, C. E. Swanson e J. P. Lea. "Expression of calcineurin activity and alpha-subunit isoforms in specific segments of the rat nephron". American Journal of Physiology-Renal Physiology 269, n.º 4 (1 de outubro de 1995): F558—F563. http://dx.doi.org/10.1152/ajprenal.1995.269.4.f558.
Dušková, M., L. Dušek, M. Čìž, A. Lojek e H. Slavíková. "The Influence of Some Immunosuppressive Drugs on the Metabolic Activity of Human Phagocytes and Lymphocytes in vitro". International Journal of Immunopathology and Pharmacology 11, n.º 3 (setembro de 1998): 155–62. http://dx.doi.org/10.1177/039463209801100305.
Hodge, Shekema, Juliette de Rosayro, Amanda Glenn, Ifeoma C. Ojukwu, Stephen Dewhurst, Harold M. McClure, Norbert Bischofberger, Daniel C. Anderson, Sherry A. Klumpp e Francis J. Novembre. "Postinoculation PMPA Treatment, but Not Preinoculation Immunomodulatory Therapy, Protects against Development of Acute Disease Induced by the Unique Simian Immunodeficiency Virus SIVsmmPBj". Journal of Virology 73, n.º 10 (1 de outubro de 1999): 8630–39. http://dx.doi.org/10.1128/jvi.73.10.8630-8639.1999.
Siekierka, John J. "Probing T-cell signal transduction pathways with the immunosuppressive drugs, FK-506 and rapamycin". Immunologic Research 13, n.º 2-3 (junho de 1994): 110–16. http://dx.doi.org/10.1007/bf02918272.
Poolos, Nicholas P. "Hypoxia Results in GABAergic Channelopathy". Epilepsy Currents 5, n.º 6 (novembro de 2005): 234–35. http://dx.doi.org/10.1111/j.1535-7511.2005.00073.x.
Esteves, Iracema, Juliana F. Fernandes, Andreza Feitosa Ribeiro, Fabio P. S. Santos, Ricardo Helman, Claudio Castro Junior, Vinicius R. P. Mattos et al. "The Clinical and Therapeutic Drug Monitoring of Oral and Intravenous Busulfan in Patients with Acute Leukemia That Underwent to Stem Cell Transplantation with a Test Dose of Busulfan". Blood 124, n.º 21 (6 de dezembro de 2014): 5841. http://dx.doi.org/10.1182/blood.v124.21.5841.5841.
Li, Dailin, Sam Xian Jun Cheng, Gilberto Fisone, Michael J. Caplan, Yoshiyuki Ohtomo e Anita Aperia. "Effects of okadaic acid, calyculin A, and PDBu on state of phosphorylation of rat renal Na+-K+-ATPase". American Journal of Physiology-Renal Physiology 275, n.º 6 (1 de dezembro de 1998): F863—F869. http://dx.doi.org/10.1152/ajprenal.1998.275.6.f863.
Karpas, A., M. Lowdell, S. K. Jacobson e F. Hill. "Inhibition of human immunodeficiency virus and growth of infected T cells by the immunosuppressive drugs cyclosporin A and FK 506." Proceedings of the National Academy of Sciences 89, n.º 17 (1 de setembro de 1992): 8351–55. http://dx.doi.org/10.1073/pnas.89.17.8351.